4//SEC Filing
Revance Therapeutics, Inc. 4
Accession 0001209191-15-043022
CIK 0001479290operating
Filed
May 13, 8:00 PM ET
Accepted
May 14, 9:16 PM ET
Size
5.5 KB
Accession
0001209191-15-043022
Insider Transaction Report
Form 4
Glasheen James Walter
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-05-07+8,000→ 8,000 totalExercise: $20.42Exp: 2025-05-06→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option shall vest on the one year anniversary of May 7, 2015, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual option grant pursuant to the Issuer's Non-Employee Director Compensation Policy.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 9:16 PM ET
- Size
- 5.5 KB